Acadia Pharma (ACAD) Misses Q2 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. QGEN
5. QS
6. BFH
7. BRO
8. SAP
9. RCUS
10. LMT

Go back to Acadia Pharma (ACAD) Misses Q2 EPS by 6c

Piper Jaffray Downgrades Acadia Pharmaceuticals (ACAD) to Neutral

August 7, 2015 7:02 AM EDT

Piper Jaffray downgraded Acadia Pharmaceuticals (NASDAQ: ACAD) from Overweight to Neutral with a price target of $48.00 (from $39.00), saying with the Pima' NDA filed the next steps may be more challenging.

Analyst Charles Duncan commented, "ACADIA ended 2Q with $271M in cash,... More

Cowen Raises Price Target on Acadia Pharma (ACAD) Following 2Q15

August 7, 2015 6:56 AM EDT

Cowen reiterated an Outperform rating on Acadia Pharmaceuticals (NASDAQ: ACAD), and raised the price target to $50.00 (from $43.00), following 2Q15 results. ACAD reported 2Q15 EPS of $(0.39) vs consensus of $(0.33).

Analyst Ritu Baral commented, "ACAD's 2Q15 call was largely uneventful with ACAD... More